Key result
Higher resting heart rate in CHF linked to ~8% greater major event risk per 10 bpm.
Why the study?
While baseline resting heart rate is a well-established prognostic marker in heart failure, limited data exist on the prognostic implications of temporal changes in resting heart rate in chronic heart failure.
Is an increase in resting heart rate over one year associated with a higher risk of cardiovascular death and heart failure hospitalization in patients with chronic heart failure?
Is an increase in resting heart rate over one year associated with a higher risk of cardiovascular death and heart failure hospitalization in patients with chronic heart failure?
An increase in resting heart rate over one year is independently associated with worse clinical outcomes in chronic heart failure, particularly in patients with sinus rhythm and reduced LVEF.
ΔRHR may refine risk stratification in CHF; leaves open whether targeting heart rate trajectories improves outcomes.
Background Resting heart rate (RHR) is a well-established prognostic marker in patients with heart failure (HF), with higher RHR associated with increased mortality and hospitalization rates1. Elevated RHR reflects increased sympathetic activity and impaired autonomic regulation, both of which result in adverse cardiovascular outcomes. While baseline RHR has been extensively studied, limited data are available regarding the prognostic implications of temporal changes in RHR (ΔRHR) in patients with chronic HF (CHF)2. Purpose We examined the association between ΔRHR (change in RHR over one year) and cardiovascular events in patients with CHF. Methods We analyzed 3,412 patients with CHF (male 2,369 (69%)/ female 1,043 (31%), mean age 67.9 years) enrolled in our multicenter, prospective CHART-2 (Chronic Heart Failure Analysis and Registry in the Tohoku District-2) Study. Time-dependent Cox regression was used to assess the relationship between ΔRHR and the composite outcome of cardiovascular death and HF hospitalization, stratified by cardiac rhythm (sinus rhythm [SR] vs. atrial fibrillation [AF]) and left ventricular ejection fraction (LVEF). Results Higher ΔRHR was consistently associated with increased risk of adverse cardiovascular outcomes across the overall cohort. After adjusting for baseline RHR and potential confounders, each 10 bpm increase in ΔRHR was significantly associated with an elevated risk of the composite outcome (adjusted hazard ratio [HR] 1.08, 95% confidence interval [CI] 1.04–1.13, P = 0.0002) (Figure). This association was particularly pronounced in patients with sinus rhythm (n=2,118; HR 1.13, CI 1.05–1.22, P = 0.0016), with the strongest relationship observed in those with SR and LVEF ≤50% (n=429; HR 1.23, CI 1.08–1.40, P = 0.0017). In contrast, the association was not significant in patients with SR and LVEF >50% (n=1,080; HR 1.10, CI 0.97–1.24, P = 0.13). In contrast, among those with atrial fibrillation, a significant association was found in patients with LVEF >50% (n=745; HR 1.10, CI 1.02–1.18, P = 0.0089), whereas no significant association was noted in those with LVEF ≤50% (n=204; HR 0.90, CI 0.80–1.02, P = 0.10). Conclusions Changes in RHR over one year were significantly associated with prognosis in patients with CHF, independent of baseline RHR. The strength of this association was particularly notable in patients with sinus rhythm and reduced LVEF, highlighting the clinical relevance of monitoring ΔRHR in HF management, especially when stratifying by LVEF and cardiac rhythm.
No takes yet. Share an insight, caveat, or question.
Susukita et al. (2025) studied this question. Each 10 bpm increase in resting heart rate over one year raised cardiovascular death or HF hospitalization risk by 8% in CHF patients, strongest in sinus rhythm with LVEF ≤50%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: